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SUMMARY At the outset, the categories of physical,
chemical, mechanical, biological and clinical prop-
erties of biomaterials are reviewed in terms of
their definitions and relevant examples. Clinical
performance for restorative materials is consid-
ered in terms of five crucial categories of factors
(operator, design, materials, site and patient).
Clinical performance assessment in actual clinical
trials is described in terms of United States Public
Health Service (USPHS) and modified USPHS cat-
egories of ratings collected from direct observa-
tions. Clinical failure analysis is characterized using
reverse s-shaped curves to summarize longevity
(failure or success) and clinical longevity for 50%
failures (CL50) is defined. Actual practice effec-
tiveness is demonstrated as being approximately
one-half of clinical trial efficacy. Types of restor-
ative dental material clinical trials are contrasted
(longitudinal versus cross-sectional, short-term
versus long-term, university-based versus prac-
tice-based research networks). Poor correlations
between laboratory test values and clinical perfor-
mance are explained. The need for risk assessment
is emphasized. Evidence-based dentistry is defined
in terms of available published information and
precautions. At this point, the evidence base for
clinical performance of biomaterials is scant.
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Introduction
In clinical practice, a dentist encounters a certain
amount of frustration when he or she is trying to
negotiate the plethora of treatment choices and com-
plicated options for various dental materials. A con-
stant series of questions ensues each time. Which
material should I use? Which one is it the best? How long
will it last? The response is always categorized into a
series of factual comments that often provide little or
no information to truly answer these questions. Use the
material with the least complicated techniques. Use this
material because it is the strongest. There are no clinical
research data about this recommendation but the company is
a reliable one in terms of product quality. The focus of the
following discourse is to decipher what all of this
information really means and decide if any real
answers can be provided. While someday it might be
possible to approach this topic from the point of the
desirable clinical properties and their connection to
specific laboratory properties, the limitations of both
make this approach unworkable at the moment. The
following are the three main thrusts: (i) explaining
biomaterials properties relative to clinical decision
making, (ii) examining the relationship between lab-
oratory testing and predictions of clinical performance
and (iii) interpreting the real value of any biomaterials
information as evidence for evidence-based decision
making.
*Based on a lecture given at the JOR Summer School 2006 sponsored
by Blackwell Munksgaard.
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Biomaterials research
Biomaterials properties
There are many schemes used to classify all the
properties associated with any biomaterial. However,
the one that seems to collect properties in the most
meaningful way (1, 2) utilizes the categories of physical,
chemical, mechanical, biological and clinical properties of
materials. In materials science and dental materials
science, most often we are concerned with properties of
solids and occasionally liquids. Consider the technical
definitions for each category and examples of actual
properties [see also Mjør 2007 (3)].
Physical properties are those that involve motion of
electrons, protons, or atoms within the solid, but which
do not involve any major changes in bonding patterns
or types. One example would be the electrical conduc-
tivity of a material. Electrons may move as a part of the
current through the material, but the material remains
as a metallic solid with the same atomic positions
throughout. The category of physical properties can be
subdivided into thermal, electrical, optical and mass
physical properties. Examples would include thermal
conductivity, thermal diffusivity, thermal expansion,
reflectivity, radiopacity, density and others.
Chemical properties are ones that involve changes in
bonding patterns and ⁄ or hydration states of the atoms
or molecules on the surfaces or within the interior of
the material. Examples would include water adsorption
(onto the surface), water absorption (into the interior),
chemical corrosion, electrochemical corrosion, biodeg-
radation and ⁄ or new chemical reactions.
Mechanical properties are those which involve the ways
in which a material responds to load. All mechanical
properties are normalized (stress, strain, modulus) and
they depend on the direction of loading (compressive,
tensile, shear), are time dependent (static versus
dynamic, strain-rate sensitivity), may involve cyclic
loading (fatigue) and involve considerations of defor-
mation that may not be uniform in all directions
(Poisson’s ratio). For any particular application, it is
crucial to discern the direction of loading (e.g. tensile)
so as to know the strength of interest (e.g. tensile
strength), strain-rate sensitivity and expected life-time
in fatigue. Even if someone is diligent enough to
commit to long-term cyclic testing to understand
fatigue, it is hard to represent the full range of
environment variations that might occur in the mouth.
In frustration, many investigators have created simula-
tors that pretend to represent different combinations of
environmental variables and produce responses typical
of perhaps, 3 years of clinical performance. Generally,
examining the time-dependent changes in mechanical
properties is the focus of these efforts.
Biological properties of biomaterials are those that
represent interfacial interactions of a material with the
hard and soft tissues and which may produce local or
systemic responses in the patient. Generally these are
ascertained through a series of cell culture tests, tissue
culture tests, small animal model tests, or human usage
tests in mammals. Examples of biological properties
include toxicity, sensitivity and mutagenicity tests.
Little information has been accumulated directly for
most biomaterials. Rather, materials have been
screened historically as clinically acceptable or not,
without fully understanding the details of biological
activity. Materials may be potentially toxic but may not
produce any major side-effects in use. Almost all
reactions depend on a combination of dose and time
in determining the observed response.
Clinical properties or clinical performance is defined in
terms of safety and effectiveness. Effectiveness is sub-
divided into a series of clinical assessments based on the
clinical acceptability (acceptable and unchanged; chan-
ged but still acceptable; unacceptable). The most
famous of the rating scales for clinical performance
was developed by Dr Gunnar Ryge (4, 5), who rated
each assessment as alfa, bravo, or charlie (or A, B, C,
respectively) for each of several clinical categories of
interest [caries resistance, maintenance of anatomical
form (resistance to wear), colour match, surface
texture, marginal integrity, marginal staining]. This
process was called the United States Public Health
Service (USPHS) method because Dr Ryge worked for
the USPHS at the time when it was first introduced.
This list of categories has been extended considerably
(modified USPHS) and now also includes occlusal
contacts, marginal contacts, resistance to fracture,
retention and many others. Collectively, the assess-
ments are used to judge the overall restoration accept-
ability or failure, as a function of the length of time in
service. These will be discussed in detail in a moment.
Clinical performance or clinical outcome factors
Remember the original questions posed by dentists.
Which material should I use? Which is the best? Which will
S . C . B A Y N E922
ª 2007 The Author. Journal compilation ª 2007 Blackwell Publishing Ltd
last longer? Now, consider the factors that might be
involved in the overall performance of any restoration
as a function of time. There are number of ways to
collect wide range of variables, but a practical way has
been introduced (6, 7). There are five categories of
variables or factors that describe many influences on
clinical outcome. Taken in a logical order, they include
operator factors, design factors, material factors, intra-
oral location factors and patient factors. Now, let us
consider the details associated with each one.
Operator factors deal with potential differences in skill
(not judgement) of different dentists. What is the
technical ability of an individual to perform a particular
procedure? That ability may be influenced by manual
dexterity affected by one’s natural psychomotor skills
and ⁄ or the effects of fatigue or ageing (loss of dexterity,
changes in manual control, visual impairments).
Clearly, there are differences among individuals.
Design factors involve judgements made by the oper-
ator in determining the appropriate cavity preparation
for the material type being used. Are cavosurface
margins created as butt joints or beveled? Are the
proximal margins flared and ⁄ or beveled? Are dentin
seats included at various positions along the pulpal
floor? Is the overall design gross retentive or adhesive?
All of these impact the transfer of stresses at the
restoration–tooth boundaries and margins.
Material factors include all the laboratory properties
that were previously discussed. What is the tensile
strength? What is the modulus? What is the coefficient
of thermal expansion? Are the values sufficient to
protect against restoration failure?
Intra-oral location factors consider the intra-oral vari-
ations in saliva, stress, temperature, or other effects in
relation to the restorative material located in (i)
anterior, premolar, or molar tooth, (ii) maxillary versus
mandibular arch, or (iii) primary versus permanent
tooth.
Patient factors involve environmental effects associ-
ated with the patient’s behaviour or genetic predis-
positions. What is the dental IQ of the patient? What is
the patient’s fluoride exposure history? What is
patient’s likelihood or risk towards caries? What is the
relative saliva production by the patient?
For any single clinical assessment, the list of impor-
tant factors may be different. Yet, the list is ordered in a
remarkably consistent way. The most important factor
in terms of affecting risk for clinical failure is operator!
Generally, operator risk is considered to be in the
neighbourhood of 50% or more of the overall risk. The
least important factor contributing to risk is generally
the restorative material. Reflecting on the original
questions from dentist, suddenly the reality is that
material is not nearly as important as the skill of the
operator. A skilled operator can make a poor material
work relatively well. An unskilled operator cannot
make even the best material work well. This point will
be revisited in a moment.
Risk assessment can be performed for any type of
factor. Once the impact of the operator can be
controlled or understood, the underlying effects in the
other categories can be revealed. For example, from a
series of well-controlled clinical trials of posterior
composite restorations placed by a highly uniform and
calibrated group of academic dentists at the University
of North Carolina, it was determined that the relative
risk for occlusal wear rate of medium-sized bonded
composites could be assigned, on the basis of intra-oral
location as approximately 100% for first molars, 60%
for second molars, 40% for second premolars and 30%
for first premolars. Thus, for a skilled operator, one
could conclude that posterior composite restorations in
first premolars are not at much risk at all and should be
selected whenever possible.
Clinical performance assessment in clinical trials
Clinical performance assessment is most frequently
performed using the USPHS or modified USPHS cate-
gories (5). These are all based on direct observation
(‘direct analyses’) of the conditions in the mouth of the
patient. However, it is possible to conduct ‘indirect
analyses’ by taking an impression of the cast of gypsum
or epoxy and then conduct laboratory analyses (such as
wear measurements) (8) or magnified inspections (such
as scanning electron microscopy on the surfaces or
margins) (9, 10).
Consider direct analyses in more detail. Remember
that these are judgements that were originally selected
on the basis of relevance in determining clinical
acceptability and were able to be performed with no
more than an explorer and mouth mirror. While many
operators now use magnification routinely as part of
chair-side procedures, that aid was not known when
the USPHS system was originally designed. Actual
selection of USPHS categories may also depend on the
restoration location. Retention may be an issue for
adhesive class V preparations but irrelevant for gross
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retention of class II restorations which are placed as
amalgam replacements.
Caries resistance is interpreted as resistance to sec-
ondary caries or recurrent caries in the neighbourhood
of the restoration of interest. Many individuals now
conclude that there may be no such event as secondary
caries (11). They interpret each incidence of caries event
as new caries. With that in mind, if one adopts simply
the point of view of caries near the restoration, then this
measures incidence in the test population of patients.
Most clinical trials select patients who are not at high
caries risk (12) and thus reports are low for most
restorative investigations. Typically, the recurrent caries
level in clinical trials is less than 3% (13) [see Baelum
et al. 2007 for a review (14)].
Tooth-coloured restorations are rated for their ability
to match the colour of the tooth into which they are
placed. A number of interesting factors contribute to
the actual rating. In clinical trials of new materials,
there is a high likelihood that the manufacturer will
only have a couple of shades (A2, A3) available for the
investigation rather than a full palate of 10–14 shades.
Therefore, a darker tooth may not have a good colour
match at the baseline. It is possible that 10% of the
restorations in a clinical trial actually start with a bravo
(or B) rating. Over long periods of time both the
restoration and tooth can change colour. With most
composites manufactured after 1990, little colour deg-
radation is anticipated in the restorative material
because of the care taken by manufacturers to add UV
stabilizers in the production of the resin. However, the
tooth may change colour intrinsically over the time.
Dentin tends to become darker and more yellow during
middle age (35–50 years). In long-term clinical trails,
small changes in restoration towards darkening may be
compensated by darkening of the tooth, resulting in a
continued good match. Even more likely is the possi-
bility that middle-aged patients’ teeth will darken and
restorations will appear lighter than originally selected.
Marginal integrity refers to the mechanical durability
of the margins. Have the margins fractured or ditched?
The appearance of good or poor integrity depends on
the position of the margin. Along relatively flat portions
of the occlusal table, a ditched margin represents a
dramatic change in surface topology. On cuspal
inclines, ditches may not be nearly obvious. While an
explorer can be helpful in detecting the disrupted
interface, detection depends on the orientation of the
explorer and the margin path. For composite restora-
tions, it is quite common to encounter remnants of
flash at the margins. Thin geometry of flash makes it
probable that it will quickly fracture away. This may
lead to an impression of a rough or fractured margin,
when in fact no important marginal changes have
taken place.
Ideally, surface texture of restorations should be
smooth. To some extent, this depends on operator
techniques and choices for polishing and burnishing
procedures. Most restorations start with highly polished
surfaces with no detectable surface texture. In earlier
times, when amalgams or composites utilized larger-
size particles as part of their formulation, it was possible
to encounter initial surface roughness, but that no
longer is a reality if proper procedures and techniques
are employed.
Anatomical form refers to the ability to resist wear. If
one only observed the surface of a restoration without
reference to the margins, it would be almost impossible
to detect changes in contours. The easiest reference for
intra-oral wear, particularly along the occlusal table, is
to compare the relative height of the restoration to the
remaining tooth structure. If the preparation was
constructed with butt joints, then this should be a
sharp demarcation in most cases and allows detection
visually or with an explorer. In almost all cases, the
restoration is expected to wear at a markedly greater
rate than the enamel at the preparation margin,
providing a quasi-reference for the process. However,
over many years or where highly wear resistant
materials are being used and the process of wear occurs
slowly, some wear occurs at the enamel margin making
it a poorer reference and may actually hide true
changes (15).
Fracture resistance refers to the bulk of the restora-
tion and not simply to the margins. Material from the
restoration may or may not be lost. This event is more
commonly observed in situations such as large class V
restorations where in the cervical third may be frac-
tured and lost, a large class II undergoing cusp fracture
with material being lost, or a class IV involving loss of
the entire incisal restoration.
Occlusal contact is determined from occlusal mark-
ings with carbon paper and reference to the original
contacts shown in reference slides at baseline. For small
posterior restorations, there typically can be two or
three occlusal contacts that may be on the tooth or
restoration (16). If they are on the tooth, then changes
may not impact the restoration at all. Also, the
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likelihood of change under these circumstances would
be small. This parameter has more meaning for a larger
restoration with initial contacts on the restoration.
Other contacts help to distribute stress and prevent any
important changes for the sole restoration contact.
What is much more important is the determination that
this tooth is actually in function and not sheltered by
the fact that it has no initial contacts at all.
The quality of a proximal contact is detected using
dental floss in most cases. Floss is snapped through the
contact and rated as a tight contact (alfa), light contact
(bravo), or no contact (charlie). The broadness of the
contact is not noted but may influence any long-term
changes in the feel of the contact.
Any post-operative sensitivity rating can become a
red herring category depending on how the informa-
tion is used. Most studies pre-select patients without
sensitivity and then measure the appearance of any
post-operative sensitivity. However, some studies
intend to study the effect of materials in reducing pre-
operative sensitivity and so this outcome is extremely
important. Unfortunately, readers of the results mis-
construe the results that low levels of post-operative
sensitivity imply that materials are reducing sensitivity
when, in fact there may be no relationship between
two things at all. When post-operative sensitivity does
arise, the normal strategy is to delay treatment from
weeks to months to see if things resolve by themselves.
In that case, the rating would change from beta-to-alfa
in transitioning to the disappearance of post-operative
sensitivity. Only in the case when a restoration required
replacement would the rating become a charlie.
Loss of retention usually can be observed only in the
case of a preparation designed with adhesive-only
retention such as for saucer-shaped class V lesions. Part
or all of the retention fails and the restoration is
discovered as missing during a recall appointment.
One of the challenges for converting all of this
information into a clinical judgement is determining
the relative importance of each category and creating a
method to combine the specific values. For example,
one might ask if there are two or three clinical events
(e.g. caries resistance, wear resistance, retention) that
are more important than others. If one only examined
the failure occurring in three categories, would they
count all equally or would there be a hierarchy of
relative value? When do you replace a restoration? If
there is significant wear and the rating is a charlie
(clinically unacceptable), does that mean that replace-
ment should occur in a timely manner? It could be that
despite the failure, there is little or no risk to the patient
and the replacement could be indefinitely deferred. No
one has ever determined a method to manage these
questions.
Clinical failure analysis
Whether one considers all direct evaluation categories
in combination or individually, it is possible to generate
a summary of survival versus time as a curve (17). It is
more typical to plot success versus time, but call it a
failure analysis. An example of the curve is shown in
Figure. 1. The curve is reverse-s shaped. Typically, this
is termed a longevity curve.
Survival decreases over time from 100% to 0%,
theoretically. Actual curves rarely go to zero. A few
restorations seem to survive indefinitely. The curve can
be reported in terms of the time to failure for half of the
restorations in the pool and that is called the clinical
longevity for 50% or CL50. Typical values for the CL50
fall into the range of 5–25 years. Points along the curve
may be reported in terms of both time and survival
rates such as the 5-year survival is 92%.
A failure curve truly represents a wide range of actual
results related to different factors. It is just the average
performance for a pool of restorations. An important
factor influencing the curve is the clinical judgement
involved in deciding when to replace a restoration. In
controlled clinical trials (CCTs), replacement generally
occurs only at the time of a failure. In clinical practice,















CL50 = 10 years
Survival (5 years) = 92%
Survival-failure terminology
Survival = f (clinician, design, materials, site, patient factors)
Theoretical
Actual
Fig. 1. Survival curve for population of restorations displaying a
typical reverse s-shape.
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before the actual failure in response to small changes or
intuition about potential failure. Therefore, a more
appropriate presentation might be something like
Fig. 2.
It is also important to recognize that failure in any
clinical trial is generally a combination of causes or
events. Imagine the situation (Fig. 3) in which early
failures are primarily driven by technical problems,
midterm events could be caused by dental caries and
long-term events might be related more to bulk
fracture.
Failure curves for controlled clinical trials (CCTs) do
not have the same CL50 as the ones observed for
materials placed by general practitioners in their nor-
mal practice. As mentioned before, the major factor
influencing the outcomes is the operator. This is
reflected in Fig. 4.
Generally, longevity observed for a CCT and private
practice are different by a factor of two. Remember that
the goals of a clinical trial are to determine the safety
and efficacy. The outcome (or performance) for a CCT is
called ‘efficacy’, while success or a private practice
situation is normally designated as ‘effectiveness’. The
ratio of the effectiveness to efficacy is generally around
0Æ45 as stated above. It is hard to know the impact of
uncalibrated evaluators, but it is expected to be a major
one (12).
Types of clinical trials
Clinical trials can be categorized in terms of their
overall design as: (a1) retrospective = examining exist-
ing databases; (a2) cross-sectional = observing data for
a fixed period of time without following the progress
of any single restoration; (a3) prospective or longitu-
dinal = designing a study and monitoring restoration
performance over the time or their length of study as:
(b1) short term = 1–5 years or long term = 5–20 years.
Clearly, long-term longitudinal clinical trials are the
most expensive and least likely to occur. There are
only a few examples. Work carried out by Wilder et al.
(18) is a famous one.
Retrospective clinical research is confounded by the
absence of adequate information about the range of
factors in play and the actual details of many aspects
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Fig. 2. Failure curves for different replacement reasons, describe a
collection or zone of failure curves observed in private practice.
The typical clinical longevity at 50% (CL50) is lower in practice





















Fig. 3. Theoretical combination of three different failure events
(a, b and c) making contributions at different times.
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diligently present all the information about a patient
pool (distribution of restorations by intra-oral location,
premolars versus molars; distribution of patients by
age, 20–40 versus 40–60 versus >60 years ; patient
gender; relative restoration size, <one-half intercuspal
distance versus large restorations; distribution of cavity
preparation types, class I versus class II; effects of
operators). It is now known that while there are only
small differences between class I and class II wear risk,
there is much greater risk for restorations wider than
one-half the intercuspal distance. Thus, any pooling of
retrospective data needs to consider these differences
in trying to meaningfully merge data from different
trials into a single group for analysis.
Cross-sectional clinical research is relatively easy to
accomplish because patients are examined once
without need for recalls. A typical cross-sectional trial
of class II restorations in patients coming to a clinic
might try to measure the number of failures observed
in posterior teeth that contained pre-existing amal-
gams, composites, or glass–ionomer restorations. As
this is simply counting observations in a uncontrolled
pool, there is no real knowledge of the five categories
of factors (operator, design, material, site, patient)
that are important for understanding failure. There is
no expectation that the groups of restorations will be
balanced in number of restorations of different
materials, age of patients, or other factors. There is
a high probability of concluding improper reasons for
failures. The actual number of failures cannot be
normalized. As a rule of thumb, it is observed that
the clinical longevity reported in these types of
studies is usually about half as great (e.g. CL50 of
12 years for molar composites in clinical practice) as
the one observed in longitudinal clinical trials (e.g.
CL50 of 20–25 years).
Longitudinal clinical trials provide the best oppor-
tunity for conducting well-controlled experiments that
are capable of answering discrete questions. In this
case, the five categories of factors influencing outcome
can be controlled, as needed. The patient pool can be
balanced by age, gender, or other important consider-
ations. The primary complaints about information
from these trials are that results do not represent the
typical outcome in private dental practices where
restorative situations might be much more challeng-
ing, patients are not ideal, dentists range widely in
technical abilities and material usage might be far less
uniform. These are certainly true. Yet, any conclusions
about outcomes would be hard to interpret because
the five categories of information under those circum-
stances would not be well known. To begin to deal
with this conundrum, practice-based research net-
works (PBRNs) have been proposed to collect infor-
mation in a more orderly manner from clinical
practices (Fig. 5).
Both university CCTs and PBRN trials are needed.
At the moment, most longitudinal clinical trials are
simply short-term ones funded by individual dental
companies to evaluate their own products, while
looking at a limited pool of restorations. A small pool
of restorations (typically n = 50) in a limited number
of patients (typically n = 20–25) makes sophisticated
statistical analysis almost impossible as the number of
factors being considered is too small. The alternative
is to use PBRNs to increase the patient pool signif-
icantly (n = 1000–2000), but give up on fully con-
trolling the design for other patient or operator
factors. PBRNs are also expensive and generally need
research training for PBRN teams involved to control
techniques of placement and evaluation of restora-
tions. At the moment, three major PBRN sites at
dental institutions (Washington–Oregon, NYU, Ala-
bama–Florida) are being funded by the National
Institute of Dental and Craniofacial Research (NIDCR)
to explore the benefits from this type of research. Dr
Ivar Mjor is one of the next presenters in this
New model, PBRN
Practice-based research network (PBRN)















• 5-10 year out recent graduates
• Part-timers in school
• Web-based calibration (FDI test)
• Digital-only practices (Web-linked)
• General dentists (n = 50–200)
Incentives:
• CE credit for participation
• Some patient payments
• Materials provided gratis





Fig. 5. Practice-based research networks (PBRNs) are a way of
combining the information analysis based on the five categories of
factors, affecting outcomes that universities normally consider
with the greater variability and much larger pool of restorations
possible in private practices. PBRNs generally succeed when the
practices and practitioners are not too diverse and have reasons for
participating in dedicated ways. Projects for PBRNs can be
corporate ones or more esoteric ones.
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workshop and will discuss the strengths and weak-
nesses of these operations [see Mjør 2007 (19)].
Prospective clinical trial designs
For any clinical research trial design, there must be a
balance between statistical design needs, availability of
patient types, levels of financial funding and details of
research questions. In some cases, it is totally imprac-
tical to ask and answer a particular question. The size
and related expense of the trial design can be prohib-
itive. This is unfortunate but part of the reality in
conducting clinical research.
A perfect example is answering the question about
the relative efficacy of fluoride releasing restorations.
There is no way to directly answer this question.
A design would need to take into account the facts
that many water supplies are fluorinated, most
patients have continuous fluoride exposure from foods
they consume, there are impacts of patient behaviours
and levels of risk are quite variable among patients.
A balanced clinical trial to understand actual dental
materials effects might require 10 000–20 000 patients
and perhaps 50 000 restorations. A PBRN might have
to follow 50 000–100 000 restorations to statistically
prove any cause and effect between restoration fluo-
ride-release and reduced caries risk. As an alternative,
one can inferentially determine the answer by observ-
ing the patterns of failures and conclude that the effect
of fluoride-release from dental materials could not be
great because the failure rates of those restoration
types seems to be high compared to all other things
(20).
The ultimate solution is to conduct many small trials
that include careful risk-analysis determination. Risk
analyses should then be combined into a predictive
model. With the input from a new trial’s results, the
predictive model would provide an estimate of the
long-term outcomes and an idea of the failure curve for
that particular pool of restorations. For the next
5–10 years, many small trials are needed to establish
this baseline.
Correlation of laboratory and clinical
testing
Despite all the energy invested into laboratory test-
ing, there are no tests that are truly predictive of
long-term clinical performance. There are a couple
of tests that seem to have limited correlation with
short-term performance and those will be addressed.
Correlation of laboratory properties with clinical performance
measures
What is sought is a series of laboratory tests that
predicts the clinical outcomes and parallels the set of
clinical performance parameters. One of the traditional
methods in doing this is to correlate microleakage tests
from thermal cycling with the clinical performance that
is measured in terms of resistance to marginal staining
or resistance to dental caries. There is absolutely no
correlation between these laboratory and clinical
events. This has been studied for more than 80 years
using a wide range of approaches and combined events
with no success at all. A recent symposium at the
American Association for Dental Research (AADR) in
Orlando (21) concluded that there is no future in
continuing these tests. All attempts were fruitless and
this was a wasted research effort. Examine for a
moment some of the reasons why this absence of
correlation occurs.
Clinical events are not nearly as well defined as one
might like. What is marginal staining? It could be caused
by penetration of small molecules associated with foods
that leave residual stains. Even a well-bonded margin
can have small molecule diffusion along its boundary. If
you use iodine as the tracer atom to detect leakage, it
can leak directly through the enamel and dentin using
available nano-channels. It diffuses more readily along
restoration margins through micro-channels associated
with the bonded layers or ones related to restorative
dentistry damage from cavity preparation. If a larger
tracer molecule is selected, it may no longer diffuse
through tooth structure, but could still invade micro-
spaces. If you wait for too short a period of time, you
might not detect any diffusion or may not encounter
degradation changes of the materials that could con-
tribute to diffusion opportunities. Not all products
degrade at the same rates or with exactly the same
mechanisms. If you run microleakage tests and perceive
one ranking order for a collection of materials in
1-week testing time, the order could be different for
1 month or 6 months. For each set of laboratory
experimental conditions, there is no confirming clinical
information that shows that the assumptions about
clinical conditions represent the average conditions
included in the laboratory test. Finally, and probably
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most importantly, the rate of change in a laboratory test
is generally an accelerated one. We have no idea of
what clinical time period might be represented by the
test. Thus, we find that nothing is predictive. Ideally,
a laboratory result for a 1-week simulation could
predict the relative acceptability of a specific clinical
event, occurring over a time period of 3 years.
Criteria for success for clinical and ⁄ or laboratory testing
Laboratory tests can produce numerical or categorical
results. For the test to have meaning, one must assign
an outcome level for the test that is associated with a
clinical outcome that is acceptable. Consider a discrete
example. One might state that for microleakage testing,
if less than 20% of the restorations showed leakage at
the dentin–enamel junction, after a 1-year duration
using silver-nitrate staining methods, then this would
correspond to less than 5% failure rate in 5 years
caused by secondary caries for class II restorations in
first molars. This connection would state the criteria for
success for the laboratory test of interest and its
corresponding clinical outcome.
In all cases, we must also consider time-dependent
responses. The clinical result considered above (less
than 5% secondary caries in 5 years) might convert
into 30% secondary caries in 10 years and 75%
secondary caries in 15 years. Refer back to the failure
curve presented earlier. Early failure levels cannot be
linearly extrapolated to predict later failure levels
because the failure curve is a reverse s-shape. With
this in mind, understand that each particular dental
product has its own reverse s-shaped curve. When you
test a cluster of related products and rank order the
results for a particular time point that does not mean
that the same order occurs at a later time. If the results
are good, you can probably expect that the reverse
s-shaped failure curves are shifted to the right for
everything, but the actual order for the individual
curves will be unknown.
Quite frequently in publications of laboratory test
results, an author infers that the order of results
indicates the goodness to badness of the clinical
performance. This is often wrong for two important
reasons. First, all results could be actually acceptable.
Second, the rank order could shift as a function of time.
For reporting results, always interpret the goodness of
the results by stating the criterion for success. If the
criterion was to have less than 20% microleakage in 1
week and all products did that, then they are all
successful. You cannot state that one is better than
another because there is no evidence in clinical trials or
any expectation that the order will occur in that same
sequence over all time points.
Suspected correlations of laboratory and clinical performance
In the oral environment, there are always many things
occurring simultaneously to a restoration. Mechanical
stresses occur cyclically during intercuspation, swal-
lowing, or chewing. Thermal stresses occur cyclically
during opening and closing one’s mouth. Water and
other ions are being actively exchanged with restora-
tions and tooth structure as a function of changing
temperatures, moisture contents, saliva flows, or
bacterial activity periods. These are just a few of the
multi-factorial events. To attempt to understand these,
laboratory testing has moved more towards laboratory
simulation that includes mechanical, temperature and
pH cycling as a quasi-representation of the oral condi-
tion. Tests attempt to mimic expected outcomes of
clinical trials for approximately 3 years. Unfortunately,
there is no agreement at this point about which types of
equipment and combination of conditions one should
use for testing.
Connect individual properties into an equation for predicting
failure
No matter what the status of laboratory testing, the
goal should be to move towards a model of risk. There
are so many different factors involved that it is difficult
for a dentist to absorb information in a clinically useful
way other than being able to calculate the risk for
failure.
By way of example, consider a second maxillary
molar tooth which has lost two cusps and is to be
restored with only a limited amount of remaining gross-
retention, no pins and amalgam. If the decision for
treatment is based on the fact that this tooth is not
expected to survive more than a few more years in
service and that the patient cannot afford other poten-
tially long-lasting alternatives, then the risk of clinical
survival might be 50% for a 3-year outcome. If that is
acceptable for that patient and dentist, then this choice
for treatment is a good one. If the desire is for
5–10 years of survival, then this is not a good choice.
If it were easy to combine the knowledge of the five
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factors contributing to survival into a real mathematical
equation and quickly calculate the risk, then this would
become a useful process for planning treatment and
understanding performance.
Evidence-based dentistry and biomaterials
research
Introduction to evidence-based dentistry
Evidence-based dentistry (EBD) has long been a goal
but only recently has come into vogue as a guiding
principle for much of the treatment or future research
that is being planned. Ernie Cochrane [after whom the
Cochrane Collaboration (22) was named] had been
active in questioning the real basis of knowledge that
we had for treatment. In the mid-1990s, when EBD
moved to the forefront, there was an estimate that only
around 8% of all of the dentistry practiced in the world
was based on legitimate scientific knowledge. Mostly, it
was a best guess (called clinical judgement) or was
simply conforming to the standard of practice (what we
have always done). The good news is at least 8% of
practice includes evidence. The bad news is that we do
not really know which part it is.
Shifting the concern to EBD does not mean that
evidence magically appears. Information for decision
making that would be considered as acceptable evi-
dence actually turns out to be quite complicated.
Ideally, evidence from a large number of long-term
clinical trials would produce good meta-analyses that
would clearly point the way for choices in treatments.
However, the knowledge base is almost non-existent.
There were only five meta-analyses published for
anything concerning restorative dental materials by
the year 2004. One of those meta-analyses examined
the clinical trials for posterior composite wear (23).
Meta-analyses depend on randomized controlled
clinical trials (RCTs) and controlled clinical trials (CCTs)
but most of the clinical research in dentistry involves
poor CCTs at best. Most are unique enough that it is
hard to combine their results into a meaningful meta-
analysis.
In lieu of good clinical information, by far, most of
the information about restorative dentistry is embedded
in a collection of huge numbers of laboratory tests. This
is emphasized by the fact that ‡600 publications for
each popular dental material product has appeared in
the literature, in response to excessive testing, during
the last couple of decades (24). Over the years, only
about 5–10% of all the information about restorative
dental materials has been associated with clinical
research (25). Clinical trials are small, short term and
limited in terms of products tested.
Laboratory research data are of limited value for the
many reasons previously presented. Most data do not
correlate with clinical outcomes, as just discussed. Most
tests do not strictly follow the same set of specifications
or standards and this limits the comparability of the
results. Most tests are performed on existing dental
materials products, which are poorly characterized
in terms of chemical composition and microstructures,
so little structure–property understandings are
forthcoming.
Another way to determine relative acceptability of
products is simply to obtain feedback from clinicians in
active practice. What materials are preferred for handling
reasons and associated with the lowest number of clinical
problems? Questionnaire information from clinicians
becomes a poor-man’s practice-based research network
(PBRN). Nothing is truly known about the clinicians or
patients. Yet, this type of survey research has become
popular and is included in Clinical Research Associates
(CRA) Newsletter, The Dental Advisor (TDA), Reality and
the American Dental Association (ADA) Professional
Products Review.
Individuals involved in laboratory research, clinical
research, discussions with clinicians in practice and
reports in publications develop impressions about the
relative acceptability or desirability of products and
provide expert opinions (opinion leaders) to the profes-
sion in commentaries, editorials, continuing dental
education courses or as consultants. Opinion about the
data is easy to collect. It also tends to drive decision
making in much of dentistry. It has been stated anec-
dotally that 85% of all the initial decisions for material
selection and use in the United States is based on
suggestions from the CRA Newsletter. That is not evi-
dence! It has value, but it has no relationship to the long-
term clinical performance information that is desired.
A great hoax perpetrated by the desire for EBD is
citing stray research articles, as evidence for a particular
choice in dental treatment. EBD is not the process of
finding a research article that agrees with your opinion
or practice patterns. EBD is a process of ‘analysing all
the existing good literature’. It is entirely parallel to the
scientific method as it asks a question, examines the
existing literature, determines method for accepting or
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excluding the literature based on its relative value,
analyses the accepted information, makes a judgement
based on that information and the cycle continues as
new information is generated. When you consider this
loop as an endless cycle, it is easy to see why a
conclusion drawn as EBD in 1995 might be considered
erroneous once new information has been reported and
a re-analysis is conducted in 2005. Perhaps, a better
way to define evidence-based dentistry is ‘best-evi-
dence-based decision making’.
In 2007, it is still fair to say that far less than 10% of
all of the information desired for clinical decision
making is really known. Should one be discouraged by
that situation? What is a practical target? Start by
considering the process of EBD collection. If you need
around 5–10 years of clinical testing to collect infor-
mation sufficient for an effective meta-analysis, then
one immediately sees that perhaps, the best one can
do is provide evidence for practice choices, as they
existed around 10 years ago. Information that reflects
clinical trials and which is older than 10 or more years
would be useful information for EBD determinations.
You can infer that about 50% of practice of dentistry
could have a strong evidence base. In the meanwhile,
the newer techniques, thoughts, or treatments will not
have a strong evidence base, yet. These will require
time to become fully documented as best choices.
Other 50% of the literature would simply be sugges-
tive and not demonstrative.
Therefore, dentistry has a long way to go to reach the
50% of EBD target value, as it has to develop a strong
foundation of clinical trial information and extract that
information in a manner that can be easily used by
individuals in clinical practice. All these are challenges
for the future.
The Cochrane Collaboration was initiated in the early
1990s as a standardized approach in analysing the
health-care literature to determine what published
information could be connected together to answer a
question. The process is elegant and thoughtful. The
problem is that literature forms a limited data set for the
process. If a couple of bad articles exist in the literature
but are accepted as the sole source for an EBD review,
then the recommendation at the end of the process
could be a gross error. This seems to have happened
quite often and that is why many of the Cochrane
Collaboration reports are strongly disputed. Another
outcome that leads to the same situation is that no
published materials are accepted for consideration and
no answers arise for important clinical questions. This
creates a ‘void’ for many clinicians – and so, they
quickly retreat to the newsletters or opinion leaders for
suggestions.
Our dental literature is quite limited in providing
excellent publications. As a back-of-the-envelope cal-
culation, consider that (i) less than 20% of all research
actually gets submitted for publication, (ii) journals
typically have acceptance rates of only 20–50% and
(iii) of the published material, Thompson Scientific
reports less than 1% of all articles are ever cited. The
last statement agrees well with the anecdotal state-
ments of readers, who conclude that only 5% of the
literature is good and only 1% is excellent. This
calculation translates into a dataset for EBD that
includes only 20% · 50% · 1% = 0Æ1% of the evi-
dence being valuable, with most the evidence being
only laboratory data.
Analysis of clinical research publication
There is a strong desire for clinical information that is so
poorly met by the existing literature, that readers may
tend to accept poor clinical research, in spite of obvious
faults or major design problems. To see if one has the
practical know-how of extracting and arranging the
information from the jungle of irrelevant data, consider
any example of a recently published clinical research
studies. Any example will do. Go to MEDLINE (http://
www.ncbi.nlm.nih.gov/entrez/query.fcgi) and enter
the search string ‘clinical AND trial AND dental AND
restoration’. Choose any article that is available via
Open Access so that you can inspect the PDF file.
Quickly scan the article. Now, ask the following
questions. Is the trial of sufficient size, to answer the main
research question (objective or purpose) in a statistically
meaningful way? Is the population of patients involved
described in detail, as far as their gender, age, tooth being
restored and restoration size is considered? Is the population of
patients or restorations, representative of the average popu-
lation of interest, for the research question? If multiple
clinicians are involved, are they being calibrated for restora-
tion placement and evaluation procedures? Are any conclu-
sions carefully qualified in terms of the limitations of the
study? How much do you think it would cost to conduct the
study? What would it have cost to conduct the study you might
like to have seen done? What would you say about the relative
value of the results in the clinical trial, for decision making for
patient care?
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Conclusion
Laboratory testing of current biomaterials products
constitutes the largest part of information reported in
the dental literature. Publications in this regard are not
comprehensive in terms of properties or extent of
available products. There are no known strong correla-
tions between laboratory testing and short-term or long-
term clinical performance. Laboratory testing should
always include a criterion for acceptability. Clinical
research reports in the dental literature for biomaterials
are extremely limited in number and value. At this
point, the evidence base for clinical performance is scant.
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